Conference Service Mandl

abstract: Der Kurs gibt einen umfassenden Überblick über den Prozess der Arzneimittelentwicklung in der Biotechnologie und der pharmazeutischen Industrie – von der Idee, über die Entwicklung und klinischen Prüfung bis letztendlich zum Markt. Das Dozenten-Team setzt sich aus renommierten Experten der pharmazeutischen Industrie, Biotech-Unternehmen, CROs und führenden Forschungsinstituten zusammen. Der Kurs besteht aus Impuls-Vorträgen und fallbezogenen praktischen Übungen, die auf jede Ebene der Arzneimittelentwicklung abzielen.

abstract: How can pharmacists best support patients in their healthcare decisions? How can the profession be supported in dealing with workplace and commercial pressures while maintaining commitment to high quality patient care? These are just some of the issues that the Royal Pharmaceutical Society will address at its new conference in 2010.

This brand new event will have a practice and professional focus and will explore patient and professional decision making - how pharmacists, as professionals, can lead the way in maximising the optimal use of medicines, maintaining the best interests of patients and in making the best possible decision during times of workplace stress. This is an opportunity for pharmacists to develop leadership skills and to network and see how such networking has been developed at local levels across the countries.

abstract: Join your colleagues at GTCbio’s The Future of Bio-Based Chemicals—Inception to Marketplace Conference, for two days of essential, timely, and informative presentations. The event will address new technologies, investment trends, and updates on exciting developments, such as the Algae and Woody-Mass feedstocks. In addition, discussions on future synergy among the bio-sectors, bio-refinery partnerships with petrol-refineries and ethanol plants, and updates on government policy will be included.

abstract: World Pharma Trials Asia is the only Asia-focused event in China in 2010, where the World’s Top Pharmas, biotechs, CROs, and regulators convene to provide the most comprehensive knowledge into the best operational strategies and practices in fast-tracking clinical drug development in Asia.

abstract: Welcome to the 3rd annual Advances in qPCR conference and exhibition. This year's event will take place in the dynamic city of Dublin, economic and cultural centre of Ireland. The conference will be co-located with RNAi & miRNA Europe, Epigenetics Europe and Genomics Automation Europe. Registered delegates will have access to all four meetings ensuring a very cost-effective trip. Make the most of your trip by also attending the co-located Training Course. Keynote Speaker Fred Kramer, Professor, New Jersey Medical School and Co-Director Laboratory of Molecular Genetics at the Public Health Research Institute Agenda Topics qPCR in Diagnostics Detection of Tumour Cells microRNA/siRNA Applications High Resolution Melt Chip / location analysis Single Cell qPCR BioStatistics & Bioinformatics Expression Profiling

abstract: Welcome to the 7th annual RNAi & miRNA Europe - Europe's largest conference & exhibition dedicated to RNA interference. This year's event will take place in the dynamic city of Dublin, economic and cultural centre of Ireland. The conference will be co-located with Advances in qPCR, Epigenetics Europe and Genomics Automation Europe. Registered delegates will have access to all four meetings ensuring a very cost-effective trip. Keynote Speaker Eric Miska, Group Leader, Cancer Research UK Gurdon Institute, University of Cambridge Agenda Topics Target Discovery and Validation Transfection siRNA Therapeutics in vivo RNAi Bioinformatics of small RNAs siRNA library screens microRNAs in : - Disease Biology - Stem Cell Biology - Diagnostics - Virology - Biogenesis - Development

abstract: This exciting event will explore current and emerging initiatives and approaches in toxicity prediction, covering and comparing tools and techniques available today and taking a look into the future at new directions and challenges. Of interest to scientists working within industry, academia, regulatory bodies and government agencies; this event offers an excellent opportunity for hearing from prestigious keynote speakers on current topics in the life sciences, and networking. Presentations from speakers working in the area of ADMET studies and representing commerce, academia and associated industry bodies.

abstract: Most strategic pharmaceutical conference focused on R&D LOCATION SELECTION, CHEMICAL vs. BIOPHARMACEUTICAL, PATENT DRUGS vs. GENERICS, CLINICAL TRIALS

abstract: This course is designed for Validation, Quality, IT, and Business personnel responsible for implementing and using regulated computer systems in the pharmaceutical, biotech and medical device industries.  The course is of special value to personnel seeking experience with computer validation and issues associated with FDA regulated computer systems.  The course is especially designed for attendees seeking a thorough introductory level of understanding, yet is also designed to be valuable to those with prior experience seeking to remain current with industry trends and approaches.

abstract: GTCbio’s 5th Assay and Drug Discovery Technologies Conference features a mixture of academic, industry and public sector experts in an intimate setting that favors the showcase of data, exchanges of ideas and networking. Professionals in the drug discovery industry and academics can get an update of exciting new developments in assay technologies and exchange ideas in developing creative approaches in the drug discovery and development process to improve the efficiency and output. Topics include cell based assays, in vitro assays, high content analysis, high throughput screening, assays for protein therapeutics and biomarker discoveries, label-free technologies, fragment based screening and more!

abstract: The Pharma CI Conference & Exhibition is the largest and best gathering of senior level pharma, biotech, medical device, and diagnostic executives in competitive/business intelligence.

abstract: Drug Analysis 2010 will be held in Antwerp, in the University Campus of Antwerp. This international symposium will be a joint meeting of two distinguished series: the 9th International Symposium on Drug Analysis and the 22nd International Symposium on Pharmaceutical and Biomedical Analysis. It follows a series of successful symposia on Drug Analysis organized by the Belgian Society of Pharmaceutical Sciences (BSPS) since 1983. This symposium will cover all aspects of pharmaceutical and biomedical analysis, including emerging domains, such as ‘omics’, process analytical technology and green analysis.

abstract: During this three-day conference, experts offer strategies to overcome critical drug safety challenges faced through-out a product’s life cycle from premarketing clinical trials all the way to postmarketing safety surveillance/vigilance, and risk management. Participants learn about current regulatory national and international standards, state-of-the art methods and techniques in premarketing testing and evaluation, quality safety-related compliance and procedures, effective signal detection and assessment, adverse event reporting, and the latest risk management approaches in the US and abroad.

abstract: In an era of regulatory scrutiny and anticipated enforcement actions for non-compliance, The Combination Products Regulatory & Compliance Summit provides actionable strategies to respond to current activity at the Office of Combination Products to protect proprietary information and create strategic partnerships to profitably leverage your existing portfolio.

abstract: Key topics of discussion include: Discussing confidentiality of agreements across boarders to significantly improve the transparency and efficiency of clinical research results Highlighting the strengths and weakness in using contract research organisations (CRO’s) in different countries across the MENA regions compared to the west Developing cost efficient clinical trial logistics to ensure stability and integrity throughout the whole clinical trial supply chain – also considering temperature sensitive products in the MENA climate Analysis of clinical tools, technology and systems including forecasting technology to meet demand Understanding regulatory challenges that may be faced in the MENA region and how they align with global standards set by the Food and Drug Administration (FDA) Examining patient recruitment strategy in the region and identifying the diverse patient pool the region has at it’s disposal

abstract: IQPC’s 2nd Anti-Infectives Summit will continue the discovery of new and innovative drug candidates with a deliberate focus on one of the most promising growth areas, antiviral therapeutics. Begin to better build and manage your anti-infective drug portfolio upon hearing from The Anti-Infectives Summit body of experts.

abstract: Developed in collaboration with R&D leaders from Pfizer, Novartis, Roche, Abbott, Merck, Asterand and others, Predictive In Vitro Models for Drug Development, Boston 28th – 29th September, is designed to increase your preclinical predictive capability specifically around safety and pharmacokinetics. The meeting will bring together safety and pharmacokinetics experts from big pharma and biotech to explore how in vitro models can transform your ability to predict clinical outcomes and increase your organization's productivity.

abstract: Welcome to the 6th annual Ion Channel Targets conference and exhibition. This year's event takes place in Washington, capital city of the United States. The conference will be co-located with Probe Discovery. Registered delegates will have access to both meetings ensuring a very cost-effective trip. Agenda Topics Ion Channels in Drug Discovery Target Identification and Validation Advances in Ion Channel Technology Ion Channels & Drug Safety (including hERG) Outsourcing Ion Channels in Disease Biology Transporter Protein Sponsorship and Exhibition

abstract: Welcome to the 2nd annual Probe Discovery conference and exhibition. This year's event takes place in Washington, capital city of the United States. The word 'probe' is a broad term which can be interpreted to mean any one of a wide variety of agents. These include active chemistries discovered in academic screening labs or in government (MLPCN or the NIH), commercially available probes (i.e. dyes, antibodies, fluorescent proteins), failed drug candidates from Pharma, whole body or cellular imaging agents, specific biomarkers or tool molecules from chemogenomics and/or systems biology efforts. The goal of this conference is to bring all of the various incarnations of probe hunters together to share experience and network to a common purpose. The conference will be co-located with Ion Channel Targets. Registered delegates will have access to both meetings ensuring a very cost-effective trip. Confirmed Speakers Hakim Djaballah, Director, Memorial Sloan Kettering Cancer Centre Rathman Chaguturu Director, University of Kansas Peter Brown Project Manager, University of Toronto Agenda Topics Failed Drug Candidates as Probes Dyes, Antibodies and Fluorescent Proteins Whole Body or Cellular Imaging Agents Tool Molecules from Chemogenomics Innovative Assay Technologies for Probe Discovery

abstract: With the ever growing challenges in patient recruitment, fewer investigators and increased costs, all leading pharmaceutical and biotech companies are embracing the design and execution of global clinical trials as part of their development strategy. With the many unique challenges that come with global trials, the Conference Forum scrupulously researched these issues to create the most comprehensive program on best partnership practices to globalize your study for clinical success.

abstract: The key objectives of the congress are:
- To provide a progressive state-of-the-art report for scientists, governmental authorities and healthcare workers with dedicated sessions for each group
- To accelerate progress in the development of vaccines
- To encourage a prophylactic approach to healthcare

abstract: The conference will focus on advanced characterisation techniques for drug delivery systems and gather scientists in formulation development and in pharmaceutical R&D from all over the world.

abstract: For the first time BIOTECHNICA and Cambridge Healthtech Institute (CHI) are featuring an important life science conference. Molecular diagnostic tools continue to drive biomedical research. Technological advances from next-generation sequencing, microarrays, quantitative PCR, microfluidics and POC enable speed, enhance sensitivity, and reduce costs. Cancer and infectious disease two diagnostic applications with widespread clinical impact are the main emphasis for Molecular Diagnostics Europe.

abstract: Due to last year's success BIOTECHNICA and Cambridge Healthtech Institute (CHI) are again featuring an important life science conference. At PEGS Europe 2010 delegates will hear over 50 presentations from international researchers, with the ability to move between two concurrent tracks to attend presentations of specific interest to them. There are also numerous other learning and networking opportunities ranging from Pre-Conference Short Courses to networking receptions and other social events.

abstract: Now in its seventh year, GTCbio’s upcoming Anti-Infectives Partnering and Deal Making-Summit is taking place on October 7th-8th, 2010 in Boston, MA. This infectious disease partnering and business development conference gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations and learn about relevant anti-infective issues and deals.This event also provides a unique venue for attendees to learn about the anti-infective business development trends, the infectious disease markets, and novel technologies that shape up the industry.

abstract: In the wake of ICC-2009, on behalf of the organizing committee of ICC2010, I am honored to announce that BIT's 2nd International Congress of Cardiology (ICC) will be held during December 7-9, 2010, Shanghai, China. Which will have 10 chapters and about 150 sessions. On December 5-7, 2009, the 1st International Congress of Cardiology (ICC-2009) was held successfully in Shanghai, China. Nearly 200 experts take part in the opening ceremony. Dr. Xiaodan Mei, the Executive Chairman of this event delivered the opening remarks to welcome all our participants. And four keynote speakers of Dr. C. Richard Conti, professor from University of Florida, Dr. Daniel Loisance, professor from Henri Mondor Hospital, Dr. Dan J. Fintel, professor from Feinberg School of Medicine and Dr. John Shryock, senior director from Gilead Sciences shared their research and made splendid speeches. During the conference, nearly 150 speakers make their contribution to it.

abstract: Europe’s most respected biopharmaceutical executives at Therapeutic Antibodies Europe. The therapeutic antibodies Europe Conference are addressing monoclonal antibody trends, topical authorization successes and clinical updates. Case studies to show the most recent antibody improvements. Representation from the most important pharmaceutical and biotech companies in the antibody market.

abstract: BioManufacturing World 2010 is the largest global conference in China that gather international and Chinese biopharmaceutical manufacturers, CMOs, regional development agencies, technocrats, solution providers and other stakeholders to come together with a common goal to facilitate manufacturing of affordable high quality vaccines and biologic drugs in China, and ultimately improve healthcare standards of the fastest growing market in the world with 1.3 billion population.

The event will feature 40+ speakers, who will share and discuss new ideas, best business strategies, most advanced technical practices and latest partnership models that will improve biomanufacturing efficiency, product quality and business profitability

abstract: Join your colleagues in an opportunity to network with over 125 leading industrial and academic experts at this three-day summit. The 6th Modern Drug Discovery and Development Summit in San Francisco, CA, on October 20th-22nd, 2010 will offer an in-depth examination of the challenges involved in the dynamic and ever-changing field of drug discovery and development. Featuring keynote plenary sessions with leaders from Roche, Theravance, Human Genome Sciences, and Novartis, This summit will include four distinct tracks: the 4th Biomarkers Discovery and Development, 2nd Cancer Targets and Therapeutics, 4th Advances in Stem Cell Discovery and Development, and 5th Biological Therapeutics.

abstract: Research in biologics has become a hot area for many large pharmaceutical companies as expiring patents, a flood of generic drugs and slowing growth in small-molecule drug pipelines have led to decreasing revenues. GTCbio`s 5th Biological Therapeutics Conference provides participants with a current look at biologics and future projects with discussions regarding developments in drug delivery techniques for biologics, modern vaccine development, antibodies, and novel protein and peptide delivery. Overcoming the issue of the role of biologics in drug discovery and how to improve upon the length of time a drug remains effective in the body will also be addressed.

abstract: With the lift of the federal ban on stem cell research, exciting opportunities and funding sources will arise. GTCbio`s 4th Advances in Stem Cell Discovery and Development Conference on October 20th-22nd, 2010 in San Francisco, CA presents its attendants with information regarding cutting-edge developments in all areas of stem cell research, including a keynote plenary session with leaders from Human Genome Sciences, Theravance, Roche, and Novartis. Discussions will cover biology, applications, regulations, pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, FDA and NIH funding policies, and private funding from the pharmaceutical industry.

abstract: As exciting new discoveries in cancer therapies emerge, GTCbio’s 2nd Cancer Targets and Therapeutics Conference discusses the latest in cancer research with some of the biggest names in the industry. The conference, part of the 6th Modern Drug Discovery and Development Summit, brings together top pharmaceutical leaders in this three-day event, which includes a plenary keynote session with speakers from Theravance, Roche, Human Genome Sciences, and Novartis. Presentations include discussions in immunotherapies, cancer vaccines, stem cells, kinase targets, inhibitors and much more. Come join your colleagues and network with top names and hear informative discussions in cancer targets and therapeutics.

abstract: Now celebrating its fourth year, GTCbio’s Biomarker Conference is one part of four distinct tracks in the 6th Modern Drug Discovery and Development Summit! This three-day event brings together the top pharmaceutical leaders to discuss comprehensive perspectives on the past and present of biomarker research. Commencing with a plenary session featuring keynote speakers from Roche, Novartis, Theravance, and Human Genome Sciences, the conference also includes discussions on novel technologies, pre-clinical and clinical aspects of biomarker discovery and development, challenges associated with biomarkers, and more. Come network with some of the biggest names in biomarkers in this timely and informative conference.

abstract: The IDDST congress is initiated by BIT Life Sciences in 2003, with 7 years¡¯ contribution in the field of drug discovery and development, it has became a leading international event for the professionals to pinpoint and identify opportunities and market needs, explore Asian demand and get updated on latest breakthroughs in drug R&D.

abstract: The 5th Annual Generics Asia Summit will bring together C-level decision makers from Generics companies, innovator pharma companies, payers, investors, regulators and health authorities to discuss business strategy and to form partnerships in an evolving industry landscape.

This is the only event in Asia to have truly substantial and relevant discussions on the hottest issues such as leveraging on brands, biosimilars, regulatory updates and collaboration opportunities between innovator pharma and traditional generics companies.

Whether you have or plan to invest in the regulated, semi-regulated or unregulated markets , this event will provide you with actual case studies on how to maximize profits and control costs in Asia’s today’s highly competitive, yet potentially lucrative exciting generics industry.

IBC’s 5th Annual Generics Asia Summit follows a highly rated programme in 2009, which brought together from last year innovators including Merck, Pfizer and Sanofi-Aventis as speakers and delegates

abstract: Pharmacovigilance Asia 2010 is a one-of-its-kind conference that will bring together regulators from across Asia together with experts in pharmacovigilance and drug safety from pharmaceutical/biotech and CROs to discuss the pressing issues faced in drug safety including how to manage risks and the varied regulatory standards. Pharmacovigilance is an essential function within any pharmaceutical/sponsor organization. Performed appropriately, companies reap the benefits of successful drug launches and long-term profits. Performed inappropriately, companies open themselves to a world of risks. Pharmacovigilance and drug safety in Asia is rapidly gaining attention with the shift of pharmaceutical activities from west to east. With an increasing number of clinical trials being held in Asia and the rapidly growing markets for both pharmaceutical products and medical devices in the region; the risks of serious adverse events (SAEs) and adverse drug reactions (ADRs) have never been greater. Every pharmaceutical/medical device company must address and manage drug safety risks and pharmacovigilance if they want to sustain the public’s confidence.

abstract: The 2nd Annual World Stem Cells & Regenerative Medicine Congress Asia 2010 brings together regional pharmas, biotechs and scientific leaders from the stem cell and regenerative medicines field to uncover Asia’s collaboration opportunities in R&D and commercialization of therapies and applications

abstract: World Stem Cells and Regenerative Medicines Congress Asia will bring together global and regional pharma, biotechs, investors and academic scientific leaders who are in the stem cell and regenerative medicines field to uncover Asia’s market potential, scientific capability and opportunities for collaborations in fast-tracking research development and commercialization of stem cell therapies and applications in the global marketplace.

abstract: The vaccine market has become one of the largest growth areas in the healthcare industry and vaccines role in public health preparedness grows ever more with immunisation being one of the greatest achievements. This congress will enhance our knowledge of the human immune response in health and disease, including news on discoveries of promising vaccine candidates for human diseases, viral immunology and immunopathogenesis. It will further encompass development and evaluation of vaccines, studies of vaccine vectors, quantitative assays of vaccine efficacy, and clinical trial studies illustrating new approaches for enhanced vaccine delivery for prophylactic and therapeutic application. Above all it will provide you with the knowledge from leading industry experts how you can boost your Vaccine R&D to lower cost and time to first dose, increase yield and optimise your vaccine pipeline to make it more attractive to potential investors.

abstract: Welcome to the 2nd annual Microarray World Congress where you will hear about the latest developments and applications in the rapidly expanding field of microarrays. This year's event will be held in San Diego. The conference will be co-located with the Lab-on-a-Chip World Congress, Molecular Diagnostics World Congress and Single Cell Analysis Summit. Registered delegates will have access to all four meetings ensuring a very cost-effective trip. Make the most of your trip by also attending the pre-conference training courses. Confirmed Speakers: Thomas Joos, Head, Biochemistry/NMI Natural and Medical Sciences Institute at the University of Tuebingen Steve Blair Associate Professor, Unviersity of Utah Bill Robinson Assistant Professor, Stanford University Seth Crosby Director, Washington University Martin Dufva Associate Professor, Technology University of Denmark Agenda Topics CGH Arrays ChIP-on-ChIP Bioinformatics for microarrays Methylation Detection Protein and Antibody Arrays Lipid Arrays Tissue Arrays Emerging Technologies

abstract: Welcome to the 2nd annual Lab-on-a-Chip World Congress, to be held in San Diego. The conference will be co-located with the Microarray World Congress, Molecular Diagnostics World Congress and Single Cell Analysis Summit. Registered delegates will have access to all four meetings ensuring a very cost-effective trip. Confirmed Speakers: Andreas Manz, Head of Research - KIST Europe Hur Koser Professor, Yale University Holger Becker Director, Microfluidic ChipShop Nicole Pamme Senior Lecturer, Hull University Jon Cooper Professor, Glasgow University Frederic Breussin Analyst, Yole Development Mehmet Yanik Professor, Massachusetts Institute of Technology Agenda Topics: Point-of-care diagnostics New applications Advances in microfabrication and engineering

abstract: Welcome to the 3rd annual Molecular Diagnostics World Congress, this year's event will be held in San Diego. The conference will be co-located with the Lab-on-a-Chip World Congress, Microarray World Congress and Single Cell Analysis Summit. Registered delegates will have access to all four meetings ensuring a very cost-effective trip. Make the most of your trip by also attending the co-located Market Analysis & Business Tutorial. Confirmed Speakers: Norman Nelson, Director of Biochemistry, Gen-Probe John Quackenbush, Professor, Harvard School of Public Health Mike Makrigiorgos Associate Professor, Dana Farber Cancer Institute Vladimir Tolstikov Director, UC Davis Enal Razvi Biotech Analyst, Select Biosciences Stephen Bodovitz Principal, Bio Perspectives Shana Kelley Professor, University of Toronto Agenda Topics Molecular Diagnostics & Biomarkers PGx and Personalized Medicine Emerging Technologies Clinical Applications of Molecular Diagnostics Commercial & Regulatory Perspectives

abstract: Welcome to the inaugural Single Cell Analysis Summit, to be held in La Jolla, San Diego. The conference will be co-located with the Lab-on-a-Chip World Congress, Microarray World Congress and Molecular Diagnostics World Congress. Registered delegates will have access to all four meetings ensuring a very cost-effective trip. Make the most of your trip by also attending the co-located Market Analysis & Business Tutorial. Confirmed Speakers: Jay Groves, Associate Professor, University of California Garry Nolan, Professor, Microbiology and Immunology StaHerbert Fritsche, MD Cancer Centre James Reuben Professor, University of Texas Laurie Jackson-Grusby Assistant Professor, Childrens Hospital Boston Oscar Ces Imperial College London Robert Murphy Professor of Biological Sciences, Carnegie Mellon University Steven Bodovitz Principal, BioPerspectives Peter Howell Principle Scientist Naval Research Laboratory Nathaniel Cady Professor, Cady Research Group, University of Albanynford Cancer Centre Agenda Topics Microarrays and Chips for Single Cell Analysis Label-Free Routes to Single Cell Analysis RT-qPCR in Single Cell Analysis Single Cell Analysis in Genetic Disorders Microfluidics and Single Cell Analysis Single Cell Analysis in Signaling

abstract: Durch Produktdesign und entsprechende Formulierungen können Produkteigenschaften verändert und gezielt an Kundenwünsche angepasst werden, ohne dass die chemische Struktur des Wirkstoffes verändert wird. Dies erfordert geeignete Produktions- und Formulierungsprozesse, um gewünschte Produkteigenschaften wie z. B. mechanische / chemische Stabilität, Zerfallskinetik, Benetzungseigenschaften oder Applikationsform erreichen zu können. Diskutiert werden die Beweggründe für neue Formulierungen, sowie die gesamte Wertschöpfungskette, anhand von Beispielen aus der pharmazeutischen und der Life-Science Industrie. Basis für diese Diskussion ist ein klar definiertes Produktprofil und die Kenntnis der verfahrenstechnischen Grundoperationen, wie auch die Eigenschaftsprofile von Rohmaterialien und Additiven. In praktischen Übungen werden ausgehend von einem Anforderungsprofil Formulierungsmöglichkeiten entwickelt, die Umsetzungsmöglichkeiten diskutiert und zum Teil im Labor erprobt.

abstract: GTCbio’s 8th Annual Vaccines: All Things Considered Conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development including research, manufacturing, regulations, investment, and policy in a comfortable, interactive and friendly setting. The 8th Vaccines: All Things Considered Conference brings together the top names in vaccinology from industry leaders like Merck, Novartis and many more, as well as from academia and the government for practical discussions of the future of our discipline.

abstract: This informative conference will provide an extensive look at the new changes and developments caused by the healthcare reform act, and what the healthcare industry and related areas are doing to adapt. Participants will have the opportunity to gain important information on how to work with the bodies that will have jurisdiction under implementing regulations, financial business models and case studies that are necessary to comply with reform, as well as hear perspectives from both side of the political spectrum. Come and join the major players in healthcare and learn how you can adapt in this challenging yet unique time.

abstract: Welcome to the 6th annual Advances in Protein Crystallography conference and exhibition. This year's event will be held in the beautiful and historic city of Florence. The conference will be co-located with Advances in Metabolic Profiling, Mass Spec Europe and European Biomarkers Summit. Registered delegates will have access to all four meetings ensuring a very cost-effective trip. Keynote Speaker Emmanuel Saridakis, Honorary Research Fellow, Imperial College London Agenda Topics Protein Chemistry and Crystallization New Laboratory Instrumentation and Techniques Advances in Diffraction Techniques and Crystallographic Computing New Drug Target Structures and their Analysis

abstract: Welcome to the 6th annual Advances in Metabolic Profiling conference and exhibition. This year's event will be held in the beautiful and historic city of Florence. The conference will be co-located with Mass Spec Europe, European Biomarkers Summit and Advances in Protein Crystallography. Registered delegates will have access to all four meetings ensuring a very cost-effective trip. Confirmed Speakers: John Shockcor, Director of Metabolic Profiling, Waters Hugh Dunstan Professor, University of Newcastle Agenda Topics Clinical Applications of Metabolomics Fluxomics and Pathway Discovery Drug Discovery and Development Plant Metabolomics Nutrigenomics and Metabolomics Microbial Metabolomics Novel Technologies for Metabolomics Bioinformatics and Data Handling for Metabolomics Data Fusion – Bringing Together Different Omic Technologies

abstract: Welcome to the 5th annual European Biomarkers Summit. This year's event will be held in the beautiful and historic city of Florence. The conference will be co-located with Advances in Metabolic Profiling, Mass Spec Europe and Advances in Protein Crystallography. Registered delegates will have access to all four meetings ensuring a very cost-effective trip. Agenda Topics Disease Specific Biomarkers Biomarkers in Genomics, Metabolomics and Translational Medicine Molecular Diagnostics, Personalized Medicine and Pharmacodiagnostics Biomarker Assay Development

abstract: Im Rahmen eines Workshops werden Inhalt, Zweck und Praxis der Health Claims-Verordnung vorgestellt. Inhalt: Schwerpunkte des Kurses sind im Wesentlichen die Anforderungen der EFSA an Health Claims. Themenschwerpunkte werden kurzfristig ergänzt Zielgruppe: Rechtsanwender - Lebensmittelindustrie (Regulatory Affairs, F&E Nahrungsergänzungsmittel, Functional Food, diätetische Lebensmittel), Marketing-Abteilungen, Werbeagenturen, Produktmanager in der Lebensmittelindustrie, Markenmanagement Kursleitung: Prof. Dr. Alfred Hagen Meyer

abstract: The key to effective internal auditing of suppliers is the training of both auditors and auditees in the purpose and relevant techniques of the audit and how these techniques can be channelled to achieve business and compliance improvements. It will cover Auditing Basics, Auditing Tools and Techniques, The Audit Process, Improving the Audit System, Added Value from Self Inspections (Level2 – QA Led)

This course will cover Auditing Basics, Auditing Tools and Techniques, The Audit Process, Improving the Audit System, Added Value from Self Inspections (Level2 – QA Led)

abstract: This 2-day interactive workshop is intended to provide an overview of the challenges that must be overcome in transferring technology and to highlight some proven techniques for overcoming those challenges.

abstract: This satellite to the 2010 meeting of the Society for Neuroscience is a joint venture between Neuropharmacology and NC-IUPHAR that will highlight how emerging structural data are providing new insights into the molecular properties of receptors, ion channels and transporters, revolutionizing pharmacological concepts, and leading to new ideas of drug discovery and development.

abstract: This one day seminar is aimed at QA staff in drug products manufacturers and especially their QPs who have specific responsibilities under directive 2004/27/EC. Participants will learn about the legislators’ perspectives and the key differences between APIs and products, which lead to different audit techniques and thought processes when auditing API manufacturers.

abstract: Objectives: * To train R & D chemists and engineers in the most efficient methods for developing cheap, robust processes used to manufacture fine organic chemicals in the minimum amount of time * To educate chemists in the principles of scale-up and development, in basic chemical engineering concepts and in techniques for the optimisation of processes * To educate chemists to learn from the experience (and mistakes) of others by examining case studies from industry Topics: Converting a synthetic route used to make gram quantities of a chemical, to a process for manufacturing tonne quantities is a topic about which much is known, but where the “tricks of the trade” are handed down within companies. There is little shared experience between chemists in different companies, and the result is a lack of awareness of what is involved in chemical development - the skills and techniques needed to efficiently scale-up chemical processes. Since many processes require chiral synthesis or use chiral catalysts, where control of conditions and optical purity are critical, the development chemist who transfers these processes to plant needs to be aware of the techniques which will lead to efficient scale-up. The course will show that the fascination of chemical development lies in its multi-disciplinary nature, from the initial interaction with research, to the liaison with chemical engineers in a production environment. A logical investigative approach to all aspects of development and scale-up will be used with many industrial case studies to illustrate the concepts. Target groups: Young Chemists who have just started work in industry as development chemists. Organic Chemists/Medicinal Chemists in Research and Development who would like to gain an appreciation of development and scale up and who are perhaps contemplating moving into chemical development. Development and Production Chemists in industry who would like to improve their efficiency and gain an insight in to alternative approaches to chemical development. Chemical Engineers who wish to understand a chemist´s approach to chemical development of batch processes (a good grounding in organic chemistry is important). Students who are about to enter the industry and can obtain company sponsorship. Organiser: Dr. Will Watson

abstract: Zielgruppe Rheologie von pharmazeutischen Produkten Forschungsleiter und Mitarbeiter, die sich mit der Entwicklung, Verarbeitung oder Qualitätskontrolle von pharmazeutischen, zahnmedizinischen, kosmetischen, biotechnischen, geonomischen, proteonomischen Produkten oder aus dem Bereich Tiermedizin und –pflege befassen. Schmelzextrusion: Forschungsleiter, Leiter der Rezepturentwicklung und erfahrene Mitarbeiter, die sich mit der Neuentwicklung oder Weiterentwicklung von bestehenden Rezepturen besonders im Hinblick auf Anforderungen in der Produktion befassen, bzw. Experten aus der Produktion bzw. Prozessentwicklung. Inhalte Rheologie von pharmazeutischen Produkten Grundlagen der Rheologie - Analyse der Eigenschaften von Emulsionen, Salben, angereicherten Hautpflegeprodukten - Quantifizierung von Hautgefühl und Stabilität - Rezepturverbesserung, Entwicklungszeit und Prozess Praktische Übungen erfolgen anschließend an rheologischen Instrumenten. Schmelzextrusion: Das Verständnis und die Bedeutung neuer Technologien wie Schmelzextrusion (Hot Melt Extrusion - HME) für die Verbesserung und Optimierung pharmazeutischer Prozesse, Produktqualität oder Kosteneinsparungen wächst zunehmend. Pharma- und Extrusionsexperten werden folgende Themen behandeln: - Verbesserte Bioverfügbarkeit und Patientenverträglichkeit - Doppelschnecken-Granulierung für die kontrollierte kontinuierliche Verarbeitung - GMP Extrusion für Implantate und transdermale Produkte - Analyse von rheologischen und mikroskopischen Strukturen - Applikationsbeispiele basierend auf den BASF Wirkstoffträger-Produkten Referenten Externer Referent und Rheologie-Spezialisten

abstract: Zielgruppe Rheologie von pharmazeutischen Produkten Forschungsleiter und Mitarbeiter, die sich mit der Entwicklung, Verarbeitung oder Qualitätskontrolle von pharmazeutischen, zahnmedizinischen, kosmetischen, biotechnischen, geonomischen, proteonomischen Produkten oder aus dem Bereich Tiermedizin und –pflege befassen. Schmelzextrusion: Forschungsleiter, Leiter der Rezepturentwicklung und erfahrene Mitarbeiter, die sich mit der Neuentwicklung oder Weiterentwicklung von bestehenden Rezepturen besonders im Hinblick auf Anforderungen in der Produktion befassen, bzw. Experten aus der Produktion bzw. Prozessentwicklung. Inhalte Rheologie von pharmazeutischen Produkten Grundlagen der Rheologie - Analyse der Eigenschaften von Emulsionen, Salben, angereicherten Hautpflegeprodukten - Quantifizierung von Hautgefühl und Stabilität - Rezepturverbesserung, Entwicklungszeit und Prozess Praktische Übungen erfolgen anschließend an rheologischen Instrumenten. Schmelzextrusion: Das Verständnis und die Bedeutung neuer Technologien wie Schmelzextrusion (Hot Melt Extrusion - HME) für die Verbesserung und Optimierung pharmazeutischer Prozesse, Produktqualität oder Kosteneinsparungen wächst zunehmend. Pharma- und Extrusionsexperten werden folgende Themen behandeln: - Verbesserte Bioverfügbarkeit und Patientenverträglichkeit - Doppelschnecken-Granulierung für die kontrollierte kontinuierliche Verarbeitung - GMP Extrusion für Implantate und transdermale Produkte - Analyse von rheologischen und mikroskopischen Strukturen - Applikationsbeispiele basierend auf den BASF Wirkstoffträger-Produkten Referenten Externer Referent und Rheologie-Spezialisten

abstract: Pharma Trials World India brings together global and Indian pharmas, biotechs, CROs and clinical trial solution providers to explore effective and efficient clinical trial development in India.

abstract: Drug Discovery World India is designed to facilitate collaboration and technology transfer for scientists, researchers, R&D executives and clinicians from research institutions, pharmas, biotechs and CROs in India.

abstract: Biologic Manufacturing World India is the only event in India where senior level executives from global and Indian biopharmas share their best practices in biologic manufacturing technology applications and outsourcing strategies.

abstract: BioPharma India Convention 2010 is where global and Indian pharmaceutical companies, biotechs, CMOs, CROs, academic institutions and many others come together to assess the latest trends, partnerships and solutions. Held concurrently are the World Pharma Trials India 2010, Biologic Manufacturing World India 2010 and R&D Partnering World India 2010.

abstract: The Inaugural Biomarker Discovery Conference will be held in magnificent Shoal Bay, NSW. It showcases the latest innovations in Biomarker Discovery using genomic, proteomic and metabolomic tools and methods. International speakers who are experts in all these fields and bioinformatics will be presenting at the meeting. Cancer and Neurobiology will be important topics and there will be specialist workshops on aspects of biomarker discovery, bioinformatics and applications.

abstract: ISOPT Asia will follow the footsteps of ISOPT 8th in Rome allowing participants to have a glimpse to the near future with critical look at the current best practices available to our patients today. ISOPT program is geared to provide a continuum, spreading from basic development of therapeutic concepts to their utilization as drugs and technologies in clinical reality. Keeping to our tradition we will be creating a comfortable atmosphere for discussions and updates. The current meeting venue, the Macau Hilton, offers magnificent options for any sort of formal and informal meetings that will complement ISOPT main hall activities.

abstract: The leading drug delivery meeting place getting you closer to the next deal

abstract: The Pharma Market Research Conference on February 1-2, 2011 at the Hilton Parsippany Hotel in New Jersey is the premier gathering for senior level pharmaceutical, biotech, medical device, and diagnostic executives in market and marketing research. Nowhere else will you find the best and brightest in pharmaceutical market research all under one roof! The Pharma Market Research Conference is your exclusive entry into the world of pharmaceutical market research. All the major players in the pharmaceutical industry are very well-represented. However, we also take great measures to make sure this conference remains intimate and exclusive. More than 200 people came in 2010! They walked away with invaluable information, meaningful interaction with the industry’s best speakers, as well as new business opportunities.

abstract: The 3rd ICDDT provides a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about the important international breakthrough developments on drug discovery and on new therapeutics. The event envisage 700 leading experts including NOBEL LAUREATES to attend talks on 35 conference tracks and over 300 poster presentations. The commercial exhibition for upto 50 exhibitors will be simultaneously organized.

abstract: With the development and improvement of modern biotechnology in recent years, antibody engineering and technologies have become one of the main stream biomedical areas and play a pivotal role in pharmaceutical and medical industries. To observe such an advance to public health, BIT Life Sciences launched ICA conference; it will present topics concerning the very current advancements in antibody research and product development. We are confident that ICA will meet the demand and offer you a focused event for updating and exchange the frontier information in the antibody academic research as well as in industrial sectors, from which you can gain deep insight from key scientific leaders dedicated to antibody discovery and development. We believe such an initiative will generate great impact on the development of antibody technology and products not only in China but also across the world.

abstract: Steroid molecules specifically control distinct aspects in cell proliferation and tissue differentiation. Dysfunctions in steroid signal transduction pathways lead to severe disorders and diminished life quality, and consequently pose an economic burden. Research in steroids so far has provided insights on biological homeostasis and how to deal with some health issues like human fertility, menopause or hypertension. However, contemporary society is facing many still unsolved issues in environmental and developmental health and aging. With the interdisciplinary nature of steroid research, involving aspects of analytics, chemistry, biology, medicine and bioinformatics, our Congress will address present state-of-the-art approaches in the molecular basis of steroid-related common human diseases like metabolic syndrome, diabetes, obesity, inflammation, and cancer. Additionally there will be ample time to enjoy plenary lectures, short oral presentations and interactive poster discussions.

abstract: Bio IT World Asia is a strategic and scientific conference where global and Asian pharmas, biotechs, research and academic institutes and solution providers discuss the latest enabling technologies and research breakthroughs that impact drug discovery pipeline.

abstract: BioPharma Asia Convention 2011 is uniquely positioned as Asia's only exhibition that showcases leading technocrats, solution and service suppliers across the entire value chain of the biopharma industry in Asia!

abstract: Pharma Trials World Asia brings together global and Asian pharmas, biotechs, CROs and clinical trial solution providers to explore effective and efficient clinical trial development in Asia.

abstract: Pharma Partnering World Asia 2011 will bring together pharmas, start-up & spin-off biotechs, research and academic institutions, professional investors, contract research service providers to network and evaluate partnering opportunities in Asia.

abstract: Drug Discovery World Asia 2011 is a strategic and scientific conference for discussing innovation, technology and partnership in driving drug discovery and pre-clinical development in Asia

abstract: Biologic Manufacturing World Asia will be the only event in Asia where senior level executives from global and Asian biopharmas share their best practices in biologic manufacturing technology applications and outsourcing strategies.

abstract: The 76th Prague Meetings on Macromolecules: Polymers in Medicine will focus on the latest innovative development in drug delivery systems. Meeting brings together multi-disciplinary researchers from both academia and industry in the areas of pharmaceutics, polymer and materials science, imaging, cell and molecular biology, genetic, and medicine.